Literature DB >> 22717317

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.

Marcello Tonelli1, Paul Muntner, Anita Lloyd, Braden J Manns, Scott Klarenbach, Neesh Pannu, Matthew T James, Brenda R Hemmelgarn.   

Abstract

BACKGROUND: Diabetes is regarded as a coronary heart disease risk equivalent-ie, people with the disorder have a risk of coronary events similar to those with previous myocardial infarction. We assessed whether chronic kidney disease should be regarded as a coronary heart disease risk equivalent.
METHODS: We studied a population-based cohort with measures of estimated glomerular filtration rate (eGFR) and proteinuria from Alberta, Canada. We used validated algorithms based on hospital admission and medical-claim data to classify participants with baseline history of myocardial infarction or diabetes and to ascertain which patients were admitted to hospital for myocardial infarction during follow-up (the primary outcome). For our primary analysis, we defined baseline chronic kidney disease as eGFR 15-59·9 mL/min per 1·73 m(2) (stage 3 or 4 disease). We used Poisson regression to calculate unadjusted rates and relative rates of myocardial infarction during follow-up for five risk groups: people with previous myocardial infarction (with or without diabetes or chronic kidney disease), and (of those without previous myocardial infarction), four mutually exclusive groups defined by the presence or absence of diabetes and chronic kidney disease.
FINDINGS: During a median follow-up of 48 months (IQR 25-65), 11,340 of 1,268,029 participants (1%) were admitted to hospital with myocardial infarction. The unadjusted rate of myocardial infarction was highest in people with previous myocardial infarction (18·5 per 1000 person-years, 95% CI 17·4-19·8). In people without previous myocardial infarction, the rate of myocardial infarction was lower in those with diabetes (without chronic kidney disease) than in those with chronic kidney disease (without diabetes; 5·4 per 1000 person-years, 5·2-5·7, vs 6·9 per 1000 person-years, 6·6-7·2; p<0·0001). The rate of incident myocardial infarction in people with diabetes was substantially lower than for those with chronic kidney disease when defined by eGFR of less than 45 mL/min per 1·73 m(2) and severely increased proteinuria (6·6 per 1000 person-years, 6·4-6·9 vs 12·4 per 1000 person-years, 9·7-15·9).
INTERPRETATION: Our findings suggest that chronic kidney disease could be added to the list of criteria defining people at highest risk of future coronary events. FUNDING: Alberta Heritage Foundation for Medical Research.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22717317     DOI: 10.1016/S0140-6736(12)60572-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  211 in total

Review 1.  Balancing ischaemia and bleeding risks with novel oral anticoagulants.

Authors:  Usman Baber; Ioannis Mastoris; Roxana Mehran
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

2.  Contrasting Cholesterol Management Guidelines for Adults with CKD.

Authors:  Lisandro D Colantonio; Usman Baber; Maciej Banach; Rikki M Tanner; David G Warnock; Orlando M Gutiérrez; Monika M Safford; Christoph Wanner; George Howard; Paul Muntner
Journal:  J Am Soc Nephrol       Date:  2014-11-13       Impact factor: 10.121

3.  Cardiovascular disease: Should CKD be considered as a coronary heart disease risk equivalent?

Authors:  Rebecca Kelsey
Journal:  Nat Rev Nephrol       Date:  2012-07-03       Impact factor: 28.314

4.  Guiding the reporting of studies that use routinely collected health data.

Authors:  Hude Quan; Tyler Williamson
Journal:  CMAJ       Date:  2016-02-16       Impact factor: 8.262

5.  Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care.

Authors:  Philip Kam-Tao Li; Guillermo Garcia-Garcia; Siu-Fai Lui; Sharon Andreoli; Winston Wing-Shing Fung; Anne Hradsky; Latha Kumaraswami; Vassilios Liakopoulos; Ziyoda Rakhimova; Gamal Saadi; Luisa Strani; Ifeoma Ulasi; Kamyar Kalantar-Zadeh
Journal:  Kidney Dis (Basel)       Date:  2020-03-11

6.  Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Hisatomi Arima; Johan Ärnlöv; Massimo Cirillo; Natalie Ebert; Jade S Hiramoto; Heejin Kimm; Michael G Shlipak; Frank L J Visseren; Ron T Gansevoort; Csaba P Kovesdy; Varda Shalev; Mark Woodward; Florian Kronenberg
Journal:  Lancet Diabetes Endocrinol       Date:  2017-07-14       Impact factor: 32.069

7.  Incremental prognostic information from kidney function in patients with new onset coronary heart disease.

Authors:  Mark A Hlatky; David Shilane; Tara I Chang; Derek Boothroyd; Alan S Go
Journal:  Am Heart J       Date:  2013-10-23       Impact factor: 4.749

8.  Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Authors:  Benjamin M Scirica; Ofri Mosenzon; Deepak L Bhatt; Jacob A Udell; Ph Gabriel Steg; Darren K McGuire; KyungAh Im; Estella Kanevsky; Christina Stahre; Mikaela Sjöstrand; Itamar Raz; Eugene Braunwald
Journal:  JAMA Cardiol       Date:  2018-02-01       Impact factor: 14.676

Review 9.  Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Authors:  Nikolaus Marx; Heidi Noels; Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-05-04       Impact factor: 5.460

Review 10.  Clinical therapeutic strategies for early stage of diabetic kidney disease.

Authors:  Munehiro Kitada; Keizo Kanasaki; Daisuke Koya
Journal:  World J Diabetes       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.